ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lidocaine hydrochloride monohydrate 21.3 mg/ml equivalent to 20 mg lignocaine hydrochloride anhydrous - oral solution - 2% w/v - active: lidocaine hydrochloride monohydrate 21.3 mg/ml equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: carmellose sodium cherry extract fache 5913g methyl hydroxybenzoate propyl hydroxybenzoate purified water saccharin sodium sodium hydroxide - xylocaine viscous solution is indicated for the relief of pain and discomfort associated with: · irritated or inflamed mucous membranes of the mouth, pharynx and upper gastrointestinal tract, e.g. post-tonsillectomy sore throat, dumping syndrome · introduction of instruments and catheters into the respiratory and gastrointestinal tract.

ベルギー - 英語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoire aguettant - lidocaine hydrochloride monohydrate 21,33 mg/ml - eq. lidocaine hydrochloride 20 mg/ml - solution for injection in pre-filled syringe - 20 mg/ml - lidocaine hydrochloride monohydrate 21.33 mg/ml - lidocaine

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

laboratoire aguettant - lidocaine hydrochloride monohydrate - solution for injection/infusion - 20 milligram(s)/millilitre - lidocaine

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - lidocaine hydrochloride monohydrate 21.3 mg/ml equivalent to lidocaine hydrochloride 2% w/v;  ;   - oral topical gel - 2% w/v - active: lidocaine hydrochloride monohydrate 21.3 mg/ml equivalent to lidocaine hydrochloride 2% w/v     excipient: amaranth blackcurrant flavour 017842 carmellose sodium hydrochloric acid purified water sodium hydroxide sodium methyl hydroxybenzoate sodium propyl hydroxybenzoate - for the relief of pain and discomfort of mucous membranes of the mouth, pharynx and upper gastrointestinal tract.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - oral liquid - excipient ingredients: sodium hydroxide; propyl hydroxybenzoate; methyl hydroxybenzoate; saccharin sodium; purified water; carmellose sodium; flavour - indicated for the relief of pain & discomfort associated with:,-irritated or inflamed mucous membranes of the mouth, pharynx and upper gastrointestinal tract, e.g. post-tonsillectomy sore throat, dumping syndrome;,-introduction of instruments and catheters into the respiratory and gastrointestinal tract

ベルギー - 英語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aspen pharma trading ltd. - lidocaine hydrochloride monohydrate 21,33 mg/ml - eq. lidocaine hydrochloride 20 mg/ml; epinephrine hydrogen tartrate 9 µg/ml - eq. epinephrine 5 µg/ml - solution for injection - lidocaine hydrochloride monohydrate 21.33 mg/ml; epinephrine bitartrate 9 µg/ml - lidocaine

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 22.7 microgram/ml (equivalent: adrenaline (epinephrine), qty 12.5 microgram/ml); lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium metabisulfite; sodium hydroxide - indications as at 25 july 2003 : lidocaine (lignocaine) solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lidocaine (lignocaine) solutions with adrenaline (epinephrine) are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

dentsply sirona (nz) limited - lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous;  ;   - solution for injection - 2 % - active: lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous     excipient: sodium chloride sodium hydroxide as 2m solution for ph adjustment water for injection

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous; lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous; lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous; lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous - solution for injection - 2 % - active: lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid as 2m solution for ph adjustment to ph 6.7-6.8 methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment to ph 6.7-.68 water for injection active: lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: sodium chloride sodium hydroxide as 2m solution for ph adjustment water for injection active: lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: sodium chloride sodium hydroxide as 2m solution for ph adjustment water for injection active: lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid sodium chloride sodium hydroxide as 2m solution for ph adjustment water for injection - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: - local infiltration - minor or major nerve blocks - epidural block - arthroscopy - intravenous regional anaesthesia

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous; lidocaine hydrochloride monohydrate 21.3 mg/g equivalent to 20 mg lignocaine hydrochloride anhydrous - topical gel - 2% w/v - active: lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid methyl hydroxybenzoate methylcellulose propyl hydroxybenzoate purified water sodium hydroxide active: lidocaine hydrochloride monohydrate 21.3 mg/g equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid hypromellose methyl hydroxybenzoate propyl hydroxybenzoate purified water sodium hydroxide - xylocaine 2% jelly is indicated as a surface anaesthetic and lubricant for: · the male and female urethra during cystoscopy, catheterisation, exploration by sound and other endourethral procedures. · nasal and pharyngeal cavities in endoscopic procedures such as gastroscopy and bronchoscopy. · during proctoscopy and rectoscopy. · tracheal intubation. · to relieve pain after circumcision in children.